Email updates

Keep up to date with the latest news and content from Diagnostic Pathology and BioMed Central.

This article is part of the supplement: Proceedings of the 11th European Congress on Telepathology and 5th International Congress on Virtual Microscopy

Open Access Proceedings

Development of a nationwide telepathology consultation and quality control program for cancer diagnosis in China

Zhongjiu Zhang1*, Guangming Gao2 and Chen Zhou3

  • * Corresponding author: Zhongjiu Zhang

Author Affiliations

1 Bureau of Health Policy and Regulation, Ministry of Health, Beijing, China

2 Division of Quality of Healthcare, Bureau of Health Policy and Regulation, Ministry of Health, Beijing, China

3 British Columbia Cancer Agency, University of British Columbia, Vancouver, Canada

For all author emails, please log on.

Diagnostic Pathology 2013, 8(Suppl 1):S6  doi:10.1186/1746-1596-8-S1-S6

Published: 30 September 2013

First paragraph (this article has no abstract)

China has the largest numbers of cancer patients worldwide but has limited pathology resources. According to a survey done by Chinese Pathologists Association, a large number of pathologists in clinical practice in China has only one year of formal or informal training. Only in recent year, formal pathology residency programs similar to those of Western countries are available in a couple of large medical schools, where limited numbers of well-trained and experienced pathologists are located. When having rare or complex cancer pathology cases, pathologists often have difficulty in making an accurate diagnosis. Mistakes in cancer diagnosis are not uncommon, which often leads to inadequate treatment of patients and medical legal problems. Thus, there is a great need for pathology consultation and quality control of cancer diagnosis in China.